Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€23.40

€23.40

0.850%
0.2
0.850%
€42.64
 
12.12.25 / Tradegate WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Agios

sharewise wants to provide you with the best news and tools for Agios, so we directly link to the best financial data sources.

News

Why Shares in Agios Pharmaceuticals Got Crushed Today: https://g.foolcdn.com/editorial/images/843604/gettyimages-1125894475-1201x801-d21b45d.jpg
Why Shares in Agios Pharmaceuticals Got Crushed Today

Shares in Agios Pharmaceuticals (NASDAQ: AGIO) crashed by 50% by noontime today. The move comes as the market digests a mixed set of topline results from its Phase 3 trial (RISE UP) of its sickle

Agios (AGIO) Q2 Revenue Jumps 45%
Agios (AGIO) Q2 Revenue Jumps 45%

Agios Pharmaceuticals (NASDAQ:AGIO), a biotechnology company focused on therapies for rare blood disorders, released its second quarter 2025 earnings on July 31, 2025. The headline was a notable